FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 343:818 September 14, 2000 Number 11 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

To the Editor: Several studies have addressed interactions between pharmaceutical companies and physicians with respect to continuing medical education, the provision of gifts and promotional materials, and research, analyzing whether and how these interactions affect the prescribing practices, attitudes, and behavior of physicians.^1,2 We analyzed trends in the use of trade names in abstracts from or presentations at scientific meetings as a way of promoting a drug.

The World Congress on Pain of the International Association for the Study of Pain, which takes place every three years, is an important forum for the dissemination of knowledge about the treatment of . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Kwo, E. C, Kamat, P., Steinman, M. A (2009). Physician Use of Brand Versus Generic Drug Names in 1993-1994 and 2003-2004. The Annals of Pharmacotherapy 43: 459-468 [Abstract] [Full Text]  
• Schwab, M., Oetzel, C., Morike, K., Jagle, C., Gleiter, C. H., Eichelbaum, M. (2002). Using Trade Names: A Risk Factor for Accidental Drug Overdose. Arch Intern Med 162: 1065-1066 [Abstract] [Full Text]  
• Ripamonti, C., Sweeney, C., Bruera, E. (2002). Use of Trade Names of Drugs and the Scientific Content of Medical Congresses. JCO 20: 1707-1708 [Full Text]